Research - NCI-CONNECTions
Rare brain and spine tumor research news and updates from NCI leading experts and collaborators. Includes articles on molecular profiling, genetic testing, and clinical studies and trials to develop better therapies.
-
NCI Neuro-Oncology Branch Chief Mark Gilbert received the American Brain Tumor Association’s Joel A. Gingras Jr. Award for spearheading brain tumor research collaborations and expanding clinical trial access.
-
Read about our advances in care, treatments, and patient outcomes for brain and other central nervous systems tumors in honor of Brain Tumor Awareness Month.
-
Five nurses attended a conference to share data from the Natural History Study, which aims to better understand brain and spine tumors and uncover areas for further research.
-
Two physicians share findings from NCI-CONNECT studies in award-winning abstracts.
-
NCI-CONNECT launched a phase 1 clinical trial for people with recurrent rare brain and spine tumors as a first step toward developing a novel drug.
-
A clinical trial investigates immune checkpoint inhibitors with standard treatment in people with aggressive brain cancers to understand the immune system response and improve long-term outcomes.
-
NCI-CONNECT launched an immunotherapy drug trial across its national network of collaborative institutions to reach more people with rare brain and spine tumors.
-
Learn how results from the first prospective clinical trial for adults with ependymoma led to a change in treatment guidelines.
-
Researchers have developed a clinical trial using virtual reality to improve the feelings of distress and anxiety that people with brain tumors experience.
-
Studying tumor tissue and clinical data across our national network of institutions will help researchers advance their knowledge of rare brain and spine tumors faster.